These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Paroxysmal nocturnal hemoglobinuria and thrombosis in the era of eculizumab]. Nishimura JI Rinsho Ketsueki; 2018; 59(8):1042-1047. PubMed ID: 30185704 [TBL] [Abstract][Full Text] [Related]
5. [Successful management of orthopedic operations requiring general anesthesia in a PNH patient after introduction of eculizumab]. Tsutsui M; Gotoh A; Yasuda H; Ono E; Tanaka M; Komatsu N Rinsho Ketsueki; 2015 Apr; 56(4):423-7. PubMed ID: 25971274 [TBL] [Abstract][Full Text] [Related]
6. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab. Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779 [TBL] [Abstract][Full Text] [Related]
7. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies. Risitano AM Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025 [TBL] [Abstract][Full Text] [Related]
8. Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria. Bauters T; Bordon V; Robays H; Benoit Y; Dhooge C J Pediatr Hematol Oncol; 2012 Nov; 34(8):e346-8. PubMed ID: 22767128 [TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial. Kanakura Y; Ohyashiki K; Shichishima T; Okamoto S; Ando K; Ninomiya H; Kawaguchi T; Nakao S; Nakakuma H; Nishimura J; Kinoshita T; Bedrosian CL; Ozawa K; Omine M Int J Hematol; 2013 Oct; 98(4):406-16. PubMed ID: 23934275 [TBL] [Abstract][Full Text] [Related]
10. Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. Risitano AM; Perna F; Selleri C Mini Rev Med Chem; 2011 Jun; 11(6):528-35. PubMed ID: 21561403 [TBL] [Abstract][Full Text] [Related]
11. A Hispanic female patient with heartburn: A rare presentation of Paroxysmal Nocturnal Hemoglobinuria. Figueroa-Jiménez LA; González-Márquez AL; Alicea-Guevara R; Santiago-Casiano M; de la Paz-López M; Negrón-Garcia L; Báez-Diaz L; Cáceres-Pérkins W Bol Asoc Med P R; 2015; 107(3):9-12. PubMed ID: 26742189 [TBL] [Abstract][Full Text] [Related]
13. C3-mediated extravascular hemolysis in PNH on eculizumab: Mechanism and clinical implications. Notaro R; Sica M Semin Hematol; 2018 Jul; 55(3):130-135. PubMed ID: 30032749 [TBL] [Abstract][Full Text] [Related]
14. Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria. Zareba KM Drugs Today (Barc); 2007 Aug; 43(8):539-46. PubMed ID: 17925885 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review. Miyasaka N; Miura O; Kawaguchi T; Arima N; Morishita E; Usuki K; Morita Y; Nishiwaki K; Ninomiya H; Gotoh A; Imashuku S; Urabe A; Shichishima T; Nishimura J; Kanakura Y Int J Hematol; 2016 Jun; 103(6):703-12. PubMed ID: 26857155 [TBL] [Abstract][Full Text] [Related]
16. Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment. Subías Hidalgo M; Martin Merinero H; López A; Anter J; García SP; Ataúlfo Gonzalez-Fernández F; Forés R; Lopez-Trascasa M; Villegas A; Ojeda E; Rodríguez de Córdoba S Immunobiology; 2017 Feb; 222(2):363-371. PubMed ID: 27644115 [TBL] [Abstract][Full Text] [Related]
17. Horse anti-thymocyte globulin and eculizumab as concomitant therapeutic approach in an aplastic paroxysmal nocturnal hemoglobinuria patient: go or no-go? Alashkar F; Dührsen U; Röth A Eur J Haematol; 2016 Oct; 97(4):403-5. PubMed ID: 26990688 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of eculizumab in a patient with paroxysmal nocturnal hemoglobinuria requiring transfusions 14 years after a diagnosis in childhood. Ueda T; Hayakawa J; Yamanishi M; Maeda M; Fukunaga Y J Nippon Med Sch; 2013; 80(2):155-9. PubMed ID: 23657069 [TBL] [Abstract][Full Text] [Related]
19. Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry. Höchsmann B; de Fontbrune FS; Lee JW; Kulagin AD; Hillmen P; Wilson A; Marantz JL; Schrezenmeier H Eur J Haematol; 2022 Sep; 109(3):197-204. PubMed ID: 35390189 [TBL] [Abstract][Full Text] [Related]
20. New insights into paroxysmal nocturnal hemoglobinuria. Savage WJ; Brodsky RA Hematology; 2007 Oct; 12(5):371-6. PubMed ID: 17852463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]